Evidence map›Paper›PMID 28223526›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

Hypermutation signature reveals a slippage and realignment model of translesion synthesis by Rev3 polymerase in cisplatin-treated yeast.

Romulo Segovia, Yaoqing Shen, Scott A Lujan, Steven J M Jones, Peter C Stirling

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Romulo SegoviaTerry Fox Laboratory, BC Cancer Agency, Vancouver, BC, Canada V5Z1L3.
Yaoqing ShenMichael Smith Genome Sciences Centre, Vancouver, BC, Canada V5Z4S6.
Scott A LujanGenome Integrity and Structural Biology Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC 27709.ORCID 0000-0003-2400-8325
Steven J M JonesMichael Smith Genome Sciences Centre, Vancouver, BC, Canada V5Z4S6.
Peter C StirlingTerry Fox Laboratory, BC Cancer Agency, Vancouver, BC, Canada V5Z1L3; pstirling@bccrc.ca.

Funding

CIHR MOP-136982
6 · The paper itself

Abstract

Gene-gene or gene-drug interactions are typically quantified using fitness as a readout because the data are continuous and easily measured in high throughput. However, to what extent fitness captures the range of other phenotypes that show synergistic effects is usually unknown. Using

Indexed as

CisplatinDNA DamageDNA-Directed DNA PolymeraseDNA RepairDNA Repair EnzymesDNA ReplicationEndonucleasesGenetic FitnessMutagenesisMutagenicity TestsMutation RateSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsWhole Genome SequencingCisplatinDNA-Directed DNA PolymeraseDNA Repair EnzymesEndonucleasesRAD1 protein, S cerevisiaeSaccharomyces cerevisiae ProteinsDNA repairgene–drug interactionmutation signaturemutatortranslesion synthesis

Identifiers

PMID28223526
PMCPMC5347559

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.